Tetrahydrocannabinolic acid

From WikiMD's WELLNESSPEDIA

Tetrahydrocannabinolic acid


Tetrahydrocannabinolic acid (THCA) is a cannabinoid that is the precursor to tetrahydrocannabinol (THC), the primary psychoactive compound found in cannabis. THCA is produced in the trichomes of the cannabis plant and is converted to THC through a process known as decarboxylation, which occurs when the plant material is heated.

Chemistry[edit]

THCA is a type of cannabinoid known as a carboxylic acid. It is produced in the cannabis plant through a process called biosynthesis, in which the enzymes THCA synthase, CBDA synthase, and CBCA synthase convert CBGA (cannabigerolic acid) into the three main cannabinoid precursors: THCA, CBDA, and CBCA.

Decarboxylation[edit]

The process of converting THCA into THC is known as decarboxylation. This process involves the removal of a carboxyl group from the THCA molecule, which occurs when the cannabis plant material is heated. The decarboxylation process can occur naturally over time or can be expedited through the application of heat, such as when cannabis is smoked or vaporized.

Pharmacology[edit]

Unlike THC, THCA is not psychoactive, meaning it does not produce the "high" associated with cannabis use. However, it does have a number of potential therapeutic benefits. Research has suggested that THCA may have anti-inflammatory, neuroprotective, and anti-emetic properties, although more research is needed to fully understand its potential medical applications.

Legal Status[edit]

The legal status of THCA varies by country and in some cases, by state or province. In many jurisdictions, THCA is considered a controlled substance due to its potential to be converted into THC.

See Also[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.